Bakri, Sophie J <br/><br/>
Pharmacokinetics of intravitreal ranibizumab (Lucentis).  [electronic resource] 

 -  Ophthalmology  Dec 2007 
 - 2179-82 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1549-4713 
<br/><br/><label>Standard No.: </label>10.1016/j.ophtha.2007.09.012  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiogenesis Inhibitors--pharmacokinetics<br/>Animals<br/>Antibodies, Monoclonal--pharmacokinetics<br/>Antibodies, Monoclonal, Humanized<br/>Aqueous Humor--metabolism<br/>Bevacizumab<br/>Biological Availability<br/>Half-Life<br/>Male<br/>Rabbits<br/>Ranibizumab<br/>Tissue Distribution<br/>Vascular Endothelial Growth Factor A--antagonists & inhibitors<br/>Vitreous Body--metabolism